S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension

Phase 4 Unknown 170 enrolled Seoul National University Bundang Hospital Hanlim Pharm. Co., Ltd. · collab

RandomizedParallel-groupOpen-labelTreatment

Summary

Evaluation of the Efficacy and Safety of S-amlodipine+Chlorthalidone Combination Therapy and S-amlodipine+Telmisartan Combination Therapy in Hypertensive Patients Inadequately Controlled With CCB(Calcium Channel Blocker) Monotherapy

Timeline

Start: 2015-12-02
Primary completion: 2018-03-31
Completion: 2018-03-31

Publications

Jo SH, Park SJ, Kim EJ, Kim SJ, Cho HJ, Song JM, Shin J, Park JJ, Shin JH, Han KR, Choi DJ. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial. Trials. 2018 Jun 20;19(1):324. doi: 10.1186/s13063-018-2636-1.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Chlorthalidone	Other / unclassified	25 mg	Oral
Comparator	Telmisartan	Other / unclassified	40 mg	Oral
Background	S-amlodipine	Unknown	2.5 mg	Oral

S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension

Summary

Timeline

Publications

Drugs

Indications